3 completed, 1 unknown. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow LY01005: new trials by email Literature Review of LY01005 trials Research Report on LY01005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer Zoladex, LY01005 - Prostate Cancer | Phase 2 | Unknown | The First Affiliated Hospital of Xiamen University | 60 | 2024-05-01 | 2024-04-26 |
| Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® LY01005, ZOLADEX® 3.6 mg - Prostate Cancer | Phase 1 | Completed | Luye Pharma Group Ltd. | 23 | 2021-02-04 | 2023-05-16 |
| Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® LY01005, ZOLADEX® 3.6 mg - Breast Cancer | Phase 3 | Completed | Luye Pharma Group Ltd. | 188 | 2020-10-15 | 2023-05-16 |
| A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer LY01005, Zoladex - Cancer of Prostate | Phase 1 | Completed | Luye Pharma Group Ltd. | 19 | 2017-12-22 | 2019-01-07 |
Prostatic Neoplasms (3) · Breast Neoplasms (1)
Luye Pharma Group Ltd. (3) · The First Affiliated Hospital of Xiamen University (1)
China (3) · United States (1)